Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176 JPY | -0.56% | +1.15% | -7.37% |
2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Sales * | - | Sales 1 * | - | Capitalization | 16.83B 106M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | 17 |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 93.47% |
1 day | -0.56% | ||
1 week | +1.15% | ||
Current month | -4.86% | ||
1 month | -2.76% | ||
3 months | -7.85% | ||
Current year | -7.37% |
Managers | Title | Age | Since |
---|---|---|---|
Shiro Akinaga
CEO | Chief Executive Officer | 67 | 20-05-31 |
Koji Fujimoto
DFI | Director of Finance/CFO | 51 | 02-10-31 |
Comptroller/Controller/Auditor | 61 | 14-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Satoru Iino
BRD | Director/Board Member | 58 | 12-02-29 |
Kazunori Kataoka
FOU | Founder | 73 | 96-06-13 |
Teruo Okano
FOU | Founder | 75 | 96-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 176 | -0.56% | 120,700 |
24-04-25 | 177 | -0.56% | 253,300 |
24-04-24 | 178 | -0.56% | 145,200 |
24-04-23 | 179 | -0.56% | 241,000 |
24-04-22 | 180 | +3.45% | 193,600 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-7.37% | 78.69M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4571 Stock